The urologists at Hackensack University Medical Center are pioneers in the field of minimally invasive robotic surgery for urological conditions. Known both nationally and worldwide for excellence in robotic surgery, our surgeons have been performing these procedures for over a decade.
Our urologists use robotic technology for a wide range of urological conditions in men and women. In fact, over 90 percent of the major urological procedures done at HackensackUMC are performed using this state-of-the-art technology. The precision of robotic technology is ideal for delicate and complex urological surgeries, allowing surgeons to perform complicated procedures while avoiding damage to surrounding structures such as fragile nerves.
The surgeons at HackensackUMC have helped develop some of this specialty’s most successful procedures, including robotic partial nephrectomy, robotic prostatectomy and complex robotic urinary reconstruction. Our surgeons teach these techniques to physicians from around the world. Our physicians have the expertise to treat both benign and cancerous conditions affecting the kidneys, bladder, pelvic organs, prostate and urinary tract.
What is robotic surgery?
Robotic surgery is a type of minimally invasive surgery during which doctors use very small surgical instruments that fit into a patient’s body through incisions that are less than a half-inch long. These instruments are mounted on three robotic arms, giving the surgeon maximum range and precision of motion during the surgery. A fourth arm holds a high-definition, three-dimensional camera that magnifies images from inside the body up to 10 times.
What are the benefits of robotic surgery?
The precision of robotic surgery allows physicians to perform complex procedures through very small incisions, avoiding the complications and longer healing time associated with traditional open surgery. Specifically, the advantages of robotic surgery may include:
Smaller incisions and less tissue damage
Increased precision for complex surgeries
Decreased blood loss (and reduced need for transfusions)
Less risk of infection
Less pain after surgery
Smaller scars, both external and internal
Shorter hospital stay
Faster recovery and return to normal activities
6 years - 255 cystectomies
~1/3 obtain a neobladder
Adopted ERAS protocol since December 2016 with following outcomes:
Average LOS 5-6 nights
16% transfusion rate
16% readmission rate
Robotic Partial Nephrectomy
80% all kidney cancers treated with partial
6 year > 600 cases
Average LOS 2 nights
Mortality < 1%
6 years – 1851 patients
Average LOS 1 night
1% transfusion rate